Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIQ
2926
DELISTED
NUVEEN INTERMEDIATE DURATION QUALITY MUNICIPAL TERM FUND
NIQ
| $10.4M | ﹤0.01% |
868,198
+44,876
| +5% | +$579K |
|
2927
Ligand Pharmaceuticals
LGND
$5.87B
| $10.4M | ﹤0.01% |
193,104
-44,478
| -19% | -$2.61M |
|
|
MAXN
2928
DELISTED
Maxeon Solar Technologies
MAXN
| $10.4M | ﹤0.01% |
4,359
+2,857
| +190% | +$5.27M |
|
|
CGC
2929
Canopy Growth
CGC
$431M
| $10.4M | ﹤0.01% |
379,302
+95,304
| +34% | +$2.94M |
|
2930
Virtus Investment Partners
VRTS
$1.13B
| $10.4M | ﹤0.01% |
64,911
-6,820
| -10% | -$1.31M |
|
2931
Agilysys
AGYS
$3.22B
| $10.4M | ﹤0.01% |
187,063
+7,438
| +4% | +$375K |
|
|
RYZ
2932
Ryerson Holding Corp
RYZ
$1.5B
| $10.4M | ﹤0.01% |
402,237
-6,851
| -2% | -$182K |
|
|
SLCA
2933
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $10.3M | ﹤0.01% |
945,032
+39,519
| +4% | +$503K |
|
2934
Apogee Enterprises
APOG
$889M
| $10.3M | ﹤0.01% |
270,603
+41,558
| +18% | +$1.69M |
|
2935
Hecla Mining
HL
$12.3B
| $10.3M | ﹤0.01% |
2,621,047
+804,158
| +44% | +$3.27M |
|
2936
Element Solutions
ESI
$9.46B
| $10.3M | ﹤0.01% |
633,812
+54,959
| +9% | +$1.03M |
|
2937
Mativ Holdings
MATV
$674M
| $10.3M | ﹤0.01% |
466,494
+155,462
| +50% | +$3.56M |
|
|
CSII
2938
DELISTED
Cardiovascular Systems, Inc.
CSII
| $10.3M | ﹤0.01% |
743,195
+36,278
| +5% | +$539K |
|
2939
Central Garden & Pet Co Class A
CENTA
$2.37B
| $10.3M | ﹤0.01% |
376,644
-25,630
| -6% | -$804K |
|
2940
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.21B
| $10.3M | ﹤0.01% |
1,001,202
+86,117
| +9% | +$1.01M |
|
2941
VictoryShares Dividend Accelerator ETF
VSDA
$252M
| $10.3M | ﹤0.01% |
260,416
-42,849
| -14% | -$1.86M |
|
2942
Alerian Energy Infrastructure ETF
ENFR
$528M
| $10.3M | ﹤0.01% |
521,383
+204,314
| +64% | +$4.4M |
|
2943
Unitil
UTL
$995M
| $10.3M | ﹤0.01% |
221,322
+20,855
| +10% | +$1.13M |
|
2944
Fulton Financial
FULT
$4.72B
| $10.3M | ﹤0.01% |
650,457
-211,136
| -25% | -$3.4M |
|
2945
Benchmark Electronics
BHE
$2.94B
| $10.3M | ﹤0.01% |
414,617
+53,330
| +15% | +$1.36M |
|
2946
iShares US Pharmaceuticals ETF
IHE
$1.64B
| $10.3M | ﹤0.01% |
181,443
-25,803
| -12% | -$1.59M |
|
2947
Varex Imaging
VREX
$779M
| $10.2M | ﹤0.01% |
484,763
+55,712
| +13% | +$1.22M |
|
|
BWIN
2948
Baldwin Insurance Group
BWIN
$3.05B
| $10.2M | ﹤0.01% |
388,784
-148,264
| -28% | -$4.22M |
|
2949
Vanguard Russell 2000 Value ETF
VTWV
$1.38B
| $10.2M | ﹤0.01% |
90,452
-2,971
| -3% | -$377K |
|
|
VBTX
2950
DELISTED
Veritex Holdings
VBTX
| $10.2M | ﹤0.01% |
384,728
-62,340
| -14% | -$1.89M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.